<i>Neisseria meningitidis</i>serogroup B bivalent factor H binding protein vaccine

Abstract excerpt

With the successful development of meningococcal vaccines against other serogroups, disease caused by Neisseria meningitidis serogroup B now accounts for a disproportionate frequency compared with other serogroups, particularly in the US and Europe. Infants and adolescents bear the highest incidence of disease, which typically manifests as meningitis and septicemia. This vaccine profile article examines a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacterial Infections and Vaccines
• Share to Influenza Virus Research Studies
• Share to Pneumonia and Respiratory Infections